BioNexus Gene Lab Corp. (NASDAQ:BGLC – Get Free Report) was the recipient of a large decrease in short interest in August. As of August 15th, there was short interest totalling 103,100 shares, a decrease of 10.5% from the July 31st total of 115,200 shares. Based on an average trading volume of 157,000 shares, the short-interest ratio is currently 0.7 days. Approximately 1.3% of the company’s stock are sold short.
BioNexus Gene Lab Stock Performance
NASDAQ BGLC remained flat at $0.44 during trading on Friday. The company’s stock had a trading volume of 60,948 shares, compared to its average volume of 117,725. BioNexus Gene Lab has a 12-month low of $0.31 and a 12-month high of $3.39. The stock has a fifty day moving average price of $0.47 and a two-hundred day moving average price of $0.58.
Institutional Trading of BioNexus Gene Lab
A hedge fund recently raised its stake in BioNexus Gene Lab stock. Virtu Financial LLC raised its stake in shares of BioNexus Gene Lab Corp. (NASDAQ:BGLC – Free Report) by 79.9% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 47,037 shares of the company’s stock after buying an additional 20,888 shares during the period. Virtu Financial LLC owned about 0.27% of BioNexus Gene Lab worth $33,000 as of its most recent SEC filing. 18.85% of the stock is currently owned by hedge funds and other institutional investors.
About BioNexus Gene Lab
BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.
See Also
- Five stocks we like better than BioNexus Gene Lab
- Investing in the High PE Growth Stocks
- Don’t Overlook Campbell Soup: Here’s What Could Drive Its Stock
- Investing in Travel Stocks Benefits
- Birkenstock’s Sudden Slide—Why It Might Be Your Next Big Win
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- MarketBeat Week in Review – 8/26 – 8/30
Receive News & Ratings for BioNexus Gene Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNexus Gene Lab and related companies with MarketBeat.com's FREE daily email newsletter.
